Biommune Pharma Technologies LLP
About Biommune Pharma Technologies LLP
Data last updated:
Biommune Pharma Technologies LLP is a limited liability partnership (LLP) based in Kolkata, West Bengal, India. It operates in the hospital and clinical services segment of the healthcare sector. It was incorporated on 04 February 2016 and has been in existence for over 10 years.
The LLP is registered with the Registrar of Companies (ROC), Kolkata, under LLPIN AAF-6355. Its GSTIN is 19AAQFB0810K1ZD (West Bengal).
The LLP has a total obligation of contribution of ₹1 Cr. It is led by designated partners including Bithin Biswas and Shib Sankar Nagsarkar.
Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at 149 Cit Road Scheme VI – M Kankurgachi, Kolkata, West Bengal, India – 700054.
The LLP has about 10 employees on its provident fund (EPFO) records.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address149 Cit Road Scheme VI – M Kankurgachi, Kolkata, West Bengal, India – 700054
- IndustryHealthcare, Hospitals
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Biommune Pharma Technologies LLP FY 2025 filings available
Financial Statement Summary of Biommune Pharma Technologies LLP
| Statement of Account and Solvency | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Income and Expenditure | |||||
| Turnover | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Income | •••• | •••• | •••• | •••• | •••• |
| Purchases and Direct Costs | •••• | •••• | •••• | •••• | •••• |
| Personnel Expenses | •••• | •••• | •••• | •••• | •••• |
| Administrative Expenses | •••• | •••• | •••• | •••• | •••• |
| Interest | •••• | •••• | •••• | •••• | •••• |
| Depreciation | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax | •••• | •••• | •••• | •••• | •••• |
| Profit After Tax | •••• | •••• | •••• | •••• | •••• |
| Profit Transferred to Partners | •••• | •••• | •••• | •••• | •••• |
| Assets and Liabilities | |||||
| Partners' Contribution | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Secured Loans | •••• | •••• | •••• | •••• | •••• |
| Unsecured Loans | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Other Liabilities and Provisions | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Loans and Advances | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Biommune Pharma Technologies LLP
| Statement of Account and Solvency | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| Net Profit Margin | •••• | •••• | •••• | •••• | •••• |
| Return on Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Return on Assets | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt to Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Turnover Growth | •••• | •••• | •••• | •••• | •••• |
| Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form 8. The full year-wise statements and ratios of Biommune Pharma Technologies are in the company report.
Financial statements from FY 2016
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Designated Partners of Biommune Pharma Technologies LLP
Biommune Pharma Technologies has 7 current designated partners and 2 former designated partners. Current designated partners are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bithin Biswas | Designated Partner | 04 Feb 2016 | 10 Years 8 Months | Current |
| Shib Sankar Nagsarkar | Designated Partner | 04 Feb 2016 | 10 Years 8 Months | Current |
| Mrityunjoy Mondal | Designated Partner | 04 Feb 2016 | 10 Years 8 Months | Current |
| Joydeb Bhattacharjee | Designated Partner | 04 Feb 2016 | 10 Years 8 Months | Current |
| Buddhadeb Biswas | Designated Partner | 04 Feb 2016 | 10 Years 8 Months | Current |
| Gopi Nath Dey | Designated Partner | 04 Feb 2016 | 10 Years 8 Months | Current |
Charges & Borrowings of Biommune Pharma Technologies LLP
Biommune Pharma Technologies LLP does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Biommune Pharma Technologies LLP
Employment history and EPFO contributions of people linked to Biommune Pharma Technologies.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Biommune Pharma Technologies LLP
Biommune Pharma Technologies LLP has 9 designated partner changes on record since 2016: 9 appointments. The latest: Aranya Sarkar was appointed as Partner on 04 Feb 2016.
Credit Ratings, Litigation & Regulatory Alerts for Biommune Pharma Technologies LLP
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Biommune Pharma Technologies LLP
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Biommune Pharma Technologies LLP
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Biommune Pharma Technologies LLP
Biommune Pharma Technologies has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 19AAQFB0810K1ZD | West Bengal | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Biommune Pharma Technologies LLP
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Biommune Pharma Technologies LLP
Biommune Pharma Technologies is an active limited liability partnership based in Kolkata, West Bengal, India. The LLP works in hospitals, within the healthcare industry. It was incorporated on 04 February 2016 (10+ years old) and is registered under LLPIN AAF-6355.
Biommune Pharma Technologies has 7 current designated partners:
- Bithin Biswas - Designated Partner
- Shib Sankar Nagsarkar - Designated Partner
- Mrityunjoy Mondal - Designated Partner
- Joydeb Bhattacharjee - Designated Partner
- Buddhadeb Biswas - Designated Partner
- Gopi Nath Dey - Designated Partner
- Arijit Sarkar - Designated Partner
The GSTIN of Biommune Pharma Technologies is 19AAQFB0810K1ZD, registered in West Bengal.
The LLPIN (Limited Liability Partnership Identification Number) of Biommune Pharma Technologies is AAF-6355. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Biommune Pharma Technologies was incorporated on 04 February 2016, making it 10+ years old. It is registered with the Registrar of Companies, Kolkata.
Aranya Sarkar was appointed as Partner on 04 Feb 2016. Arijit Sarkar was appointed as Designated Partner on 04 Feb 2016. Bithin Biswas was appointed as Designated Partner on 04 Feb 2016. Biommune Pharma Technologies has 9 designated partner changes on record in total.
The registered office of Biommune Pharma Technologies is at 149 Cit Road Scheme VI – M Kankurgachi, Kolkata, West Bengal, India – 700054.
The total obligation of contribution is ₹1 Cr.
Biommune Pharma Technologies operates in the healthcare industry, in the hospitals segment.
Biommune Pharma Technologies has about 10 employees on its provident fund (EPFO) records, the latest count available.